Table 3: Conditional risk model evaluating the effect of covariates on time to recovery.
Patient characteristics |
Hazard Ratio |
P-value |
[95% Confidence Interval] |
|
Start regimen |
||||
TDF + 3TC + EFV |
Ref |
|||
TDF + 3TC + LVP\r |
0.9 |
0.719 |
0.52 |
1.58 |
TDF + 3TC + NVP |
0.89 |
0.343 |
0.7 |
1.13 |
Gender |
||||
Female |
Ref |
|||
Male |
0.68 |
0.013 |
0.51 |
0.92 |
Age group |
||||
Pediatric |
Ref |
|||
Adult |
0.66 |
0.029 |
0.46 |
0.96 |
CD4 count |
||||
Low |
Ref |
|||
Normal |
0.91 |
0.421 |
0.72 |
1.14 |
Hemoglobin level |
||||
Low |
Ref |
|||
Normal |
0.78 |
0.054 |
0.61 |
1 |
ALT/GPT levels |
1.01 |
0.044 |
1 |
1.01 |
Viral Load |
||||
Undetectable VL |
Ref |
|||
< 1000 copies |
0.91 |
0.654 |
0.6 |
1.37 |
> 1000 copies |
1.08 |
0.601 |
0.81 |
1.42 |